Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
CDC14A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
LINC01296 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
FYB - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NBN - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CACNG8 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CREM - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC101929269 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CD55 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CAND1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ZYX - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
EMX1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PHF3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MSH4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
IL17RD - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FCF1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GRAP - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on